Friday 13, are my kind of days! Well folks here is the Test of Faith, are you walking away with some money back or wait until Monday 16,? Which could be worst or could be better ... only time and Shaka really know.
February 11th, 2009 Genta Submits randomized study of Tesetaxel in Patients with Advanced Gastric Cancer to FDA for Special Protocol Assessment February 9th, 2009 Genta Incorporated to Release Fourth Quarter Financial Results and Host Conference Call February 2nd, 2009 Genta Incorporated to Present at the 11th Annual BIO CEO & Investor Conference January 14th, 2009 Genta Initiates New Clinical Trial of Tesetaxel, the Leading Oral Taxane in Clinical Development January 12th, 2009 Genta Updates Progress of its late-stage Phase 3 Trial of Genasense ® in Advanced Melanoma January 8th, 2009 Genta Announces Issuance of Two Key U.S. Patents for its franchise Gallium Products January 5th, 2009 Genta Summarizer Phase 2 Activity and Receives Orphan Drug Designation for Tesetaxel in Gastric Cancer, a Leading Oral Taxane in Clinical Development
News 
Market Data 
Discover 
